ENTELEXO BIOTHERAPEUTICS
Entelexo Biotherapeutics develops treatments intended to assist in the treatment of immune-mediated diseases. Its treatment includes a new class of drugs which include extracellular vesicles (EVs) that are derived from stem cells, enabling healthcare workers to treat autoimmune diseases.
ENTELEXO BIOTHERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.entelexo.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Nginx
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Seed Round - Entelexo Biotherapeutics
Official Site Inspections
http://www.entelexo.com Semrush global rank: 6.03 M Semrush visits lastest month: 1.35 K
- Host name: romanlimousine.com
- IP address: 69.164.208.41
- Location: Newark United States
- Latitude: 40.739
- Longitude: -74.1697
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07175
More informations about "Entelexo Biotherapeutics"
Entelexo – Novel methods of engineering therapeutic exosomes
Entelexo offers a new approach to treating autoimmune diseases by focusing on the patients, analyzing patterns, and utilizing data to optimize product efficacy. Our engineered exosomes …See details»
Entelexo Biotherapeutics - Crunchbase Company …
Entelexo Biotherapeutics is located in Irvine, California, United States. Who invested in Entelexo Biotherapeutics? Entelexo Biotherapeutics has 2 investors including Founders, Inc. and Y Combinator. When was the last funding round …See details»
Entelexo Company Profile 2024: Valuation, Funding & Investors
Entelexo General Information Description. Developer of modern treatments designed to assist immune-mediated diseases. The company specializes in creating a new class of drugs which …See details»
Entelexo Biotherapeutics - LinkedIn
Entelexo Biotherapeutics | 34 followers on LinkedIn. Entelexo has created a novel platform technology for engineering exosomes as a new approach to treating diseases. | Entelexo …See details»
Entelexo Biotherapeutics, Inc. - Company Profile - Corporation Wiki
Dec 1, 2020 Entelexo Biotherapeutics, Inc. Overview. Entelexo Biotherapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, …See details»
Entelexo Biotherapeutics, Inc. Irvine, CA - filing information
Dec 1, 2020 Entelexo Biotherapeutics, Inc. is a business entity based in Irvine, CA. Established recently on December 1, 2020, this Unincorporated Association is recognized under the …See details»
Entelexo Biotherapeutics - Overview, News & Similar companies ...
Entelexo Biotherapeutics Inc is a company that operates in the Drug Stores & Pharmacies industry. It employs 10to19 people and has 1Mto5M of revenu e. The company is …See details»
Entelexo Biotherapeutics - VentureRadar
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology. ... Find out more about Entelexo Biotherapeutics, …See details»
ENTELEXO BIOTHERAPEUTICS, INC. | California Companies Directory
ENTELEXO BIOTHERAPEUTICS, INC. was registered on 01 Dec 2020 as company type incorporated at 5270 CALIFORNIA AVE STE 300 IRVINE CA 92617. The agent name of this …See details»
Entelexo Biotherapeutics - Funding, Financials, Valuation & Investors
Mar 25, 2021 Entelexo Biotherapeutics has raised 1 round. This was a Seed round raised on Mar 25, 2021. Entelexo Biotherapeutics is funded by 2 investors. Founders, Inc. and Y …See details»
Entelexo Biotherapeutics: Drug pipelines, Patents, Clinical trials ...
Aug 3, 2023 Explore Entelexo Biotherapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
Entelexo Biotherapeutics - Y Combinator
Dr. Riazifar has worked on stem cells over a decade and on exosomes a subclass of stem cell derived extracellular vesicles since 2012. During his Ph.D studies at the Stem Cell Research …See details»
Entelexo Biotherapeutics - Products, Competitors, Financials, …
About Entelexo Biotherapeutics. Entelexo Biotherapeutics specializes in engineering therapeutic exosomes within the biopharmaceutical industry. The company develops exosome-based …See details»
Entelexo.com - Company Profile - Tracxn
Oct 20, 2024 Entelexo.com ranks 227th among 348 active competitors. 137 of its competitors are funded while 85 have exited. Overall, Entelexo.com and its competitors have raised over …See details»
Entelexo Biotherapeutics - Contacts, Employees, Board Members, …
Organization. Entelexo Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»
Entelexo (YC W21): Creating a new class of drugs to address …
Entelexo.com. Irvine, CA Technology Healthcare Biotech Moonshots Science & R&D. Overview Details Updates. 5 What People Say. 15 Ask a Question. 5 Highlights. 1 >$1M raised to date, …See details»
Autoimmune diseases (Entelexo) - Drug Targets, Indications, …
Autoimmune diseases (Entelexo), Initially developed by Entelexo Biotherapeutics, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases, Active …See details»
Entelexo.com - Raised $125K Funding from 2 investors - Tracxn
Nov 20, 2024 Entelexo.com has raised a total funding of $125K over 1 round from 2 investors. Investors include Y Combinator and Metaplanet. Their latest funding round was of $125K on …See details»
Entelexo Biotherapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Entelexo Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 22. Monthly …See details»
Entelexo (YC W21): Creating a new class of drugs to address …
Invest as little as $100 in startups and small businesses. Wefunder is the largest Regulation Crowdfunding portal.See details»